CGEN News and Press, Compugen Ltd.

2024-07-05 07:18:27 ET More on Roche Roche: Obesity Treatment's Promise Isn't Enough More Of The Same Isn't Good Enough For Roche Roche Is Joining The Obesity Party But Questions Remain Roche's crovalimab wins FDA approval for paroxysmal nocturnal hemoglobinu...

Compugen to Present at Upcoming Antibody Industrial Symposium PR Newswire HOLON, Israel , June 17, 2024 /PRNewswire/ -- Compugen Ltd. (Nasdaq: CGEN) (TASE: CGEN), a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, t...

Compugen to Receive Milestone Payment Triggered by Dosing of First Patient in the Second Phase 3 Trial Evaluating Rilvegostomig PR Newswire Phase 3 trial evaluating rilvegostomig as monotherapy and in combination with AstraZeneca and Daiichi Sankyo's datopotamab deruxtecan in ...

A look at the top 10 most actives in the United States Greenwave Technology Solutions Inc. (GWAV) rose 33.8% to $0.0788 on volume of 1,221,538,672 shares Akoustis Technologies Inc. (AKTS) rose 128.8% to $0.3151 on volume of 536,119,838 shares Crown Electrokinetics Corp. (CRKN) rose 3.1% t...

2024-05-21 09:00:12 ET Asthika Goonewardene from Truist Financial issued a price target of $4.00 for CGEN on 2024-05-21 07:48:00. The adjusted price target was set to $4.00. At the time of the announcement, CGEN was trading at $1.74. The overall price target consensus is...

2024-05-20 12:22:10 ET Compugen Ltd. (CGEN) Q1 2024 Earnings Call Transcript May 20, 2024, 08:30 AM ET Company Participants Yvonne Naughton - Head of IR & Corporate Communications Anat Cohen-Dayag - President and CEO Alberto Sessa - CFO Eran Ophir - CSO ...

2024-05-20 07:05:49 ET More on Compugen Compugen names David Silberman as finance chief Compugen GAAP EPS of $0.11 beats by $0.01, revenue of $33.46M beats by $13.46M Seeking Alpha’s Quant Rating on Compugen Historical earnings data for Compugen ...

Inpixon (INPXV) is expected to report for Q1 2024 Siebert Financial Corp. (SIEB) is expected to report for Q1 2024 Greenwave Technology Solutions Inc. (GWAV) is expected to report for Q1 2024 Bank Hapoalim B.M. ADR (BKHYY) is expected to report for Q1 2024 Gelesis Holdings, Inc. (...

Compugen Reports First Quarter 2024 Results PR Newswire Enrollment completed and on track to present data from COM701 + COM902 + pembrolizumab platinum resistant ovarian cancer study in Q4 2024 Data from COM701 + COM902 + pembrolizumab study in microsatellite sta...

2024-05-19 08:02:00 ET Retailers will also be in the spotlight, with updates anticipated from Target ( NYSE: TGT ), Lowe's ( LOW ), Macy’s ( M ), Ross Stores ( ROST ), TJX Companies ( TJX ), Ralph Lauren ( RL ) and Urban Outfitters ( URBN ).... R...